These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Impact of Sacrospinous Hysteropexy and Vaginal Hysterectomy With Suspension of the Uterosacral Ligaments on Sexual Function in Women With Uterine Prolapse: A Secondary Analysis of a Randomized Comparative Study. Detollenaere RJ, Kreuwel IA, Dijkstra JR, Kluivers KB, van Eijndhoven HW. J Sex Med; 2016 Feb; 13(2):213-9. PubMed ID: 26805940 [Abstract] [Full Text] [Related]
11. Anatomic outcomes after pelvic-organ-prolapse surgery: comparing uterine preservation with hysterectomy. Marschalek J, Trofaier ML, Yerlikaya G, Hanzal E, Koelbl H, Ott J, Umek W. Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():33-6. PubMed ID: 25461349 [Abstract] [Full Text] [Related]
12. Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse. Hickman LC, Tran MC, Paraiso MFR, Walters MD, Ferrando CA. Int Urogynecol J; 2022 Jul; 33(7):2005-2012. PubMed ID: 34586437 [Abstract] [Full Text] [Related]
13. Guideline No. 413: Surgical Management of Apical Pelvic Organ Prolapse in Women. Geoffrion R, Larouche M. J Obstet Gynaecol Can; 2021 Apr; 43(4):511-523.e1. PubMed ID: 33548503 [Abstract] [Full Text] [Related]
14. [Effectiveness of vaginal high uterosacral ligament suspension for treatment of recurrent pelvic organ prolapse]. Shen WJ, Lu YX, Liu X, Liu JX, Duan L, Zhang YH, Niu K, Wang WY, Qin L, Zhang XL. Zhonghua Fu Chan Ke Za Zhi; 2019 Apr 25; 54(4):232-238. PubMed ID: 31006188 [Abstract] [Full Text] [Related]
15. Transvaginal uterosacral ligament hysteropexy: a video tutorial. Milani R, Frigerio M, Spelzini F, Manodoro S. Int Urogynecol J; 2017 May 25; 28(5):789-791. PubMed ID: 27942792 [Abstract] [Full Text] [Related]
17. Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial. Schulten SFM, Detollenaere RJ, Stekelenburg J, IntHout J, Kluivers KB, van Eijndhoven HWF. BMJ; 2019 Sep 10; 366():l5149. PubMed ID: 31506252 [Abstract] [Full Text] [Related]
18. [A five-year analysis of effect on transvaginal high uterosacral ligament suspension with or without native-tissue repair for middle compartment defect]. Zhang YH, Lu YX, Liu X, Liu JX, Shen WJ, Zhao Y, Niu K, Wang WY. Zhonghua Fu Chan Ke Za Zhi; 2019 Jul 25; 54(7):445-451. PubMed ID: 31365956 [Abstract] [Full Text] [Related]
19. [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence]. Hu CD, Chen YS, Yi XF, Ding JX, Feng WW, Yao LQ, Huang J, Zhang Y, Hu WG, Zhu ZL, Hua KQ. Zhonghua Fu Chan Ke Za Zhi; 2011 Feb 25; 46(2):94-100. PubMed ID: 21426765 [Abstract] [Full Text] [Related]
20. Uterine-preserving surgeries for the repair of pelvic organ prolapse: a systematic review with meta-analysis and clinical practice guidelines. Meriwether KV, Balk EM, Antosh DD, Olivera CK, Kim-Fine S, Murphy M, Grimes CL, Sleemi A, Singh R, Dieter AA, Crisp CC, Rahn DD. Int Urogynecol J; 2019 Apr 25; 30(4):505-522. PubMed ID: 30741318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]